Key Developments: IDEXX Laboratories Inc (IDXX.OQ)

IDXX.OQ on NASDAQ Stock Exchange Global Select Market

138.72USD
22 May 2015
Change (% chg)

$0.69 (+0.50%)
Prev Close
$138.03
Open
$138.47
Day's High
$139.63
Day's Low
$137.40
Volume
141,049
Avg. Vol
139,276
52-wk High
$168.49
52-wk Low
$113.69

Search Stocks

Latest Key Developments (Source: Significant Developments)

IDEXX Laboratories Inc Lowers FY 2013 Revenue Guidance; Raises FY 2013 EPS Guidance-Conference Call
Thursday, 25 Jul 2013 12:00pm EDT 

IDEXX Laboratories Inc announced that revenues for fiscal 2013 expected to be $1.37 billion to $1.38 billion reflecting expected full year organic revenue growth of 7.0% to 7.5%, down from previous guidance of 7.5% to 8.0% due to organic revenue growth in the second quarter and an anticipated reduction in capital equipment sales relative to previous expectations. Reported revenue growth is projected at 6.0% to 6.5% which is down from our previous guidance of 7.0% to 7.5% due to the reduction in expected full year organic revenue growth and unfavorable changes in foreign currency exchange rates. EPS is expected to be $3.42 to $3.48 compared to previous guidance of $3.40 to $3.46. The increase in EPS from previous guidance is due to revised share count estimates reflecting our latest assumptions on share repurchase. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report revenue of $1.37 billion and EPS of $3.46 for fiscal 2013.  Full Article

IDEXX Laboratories Inc Lowers FY 2013 EPS Guidance-Conference Call
Tuesday, 11 Jun 2013 10:30am EDT 

IDEXX Laboratories Inc announced that for fiscal 2013, it expects earnings guidance to be $3.40 to $3.46. According to I/B/E/S Estimates, analysts on an average were expecting the Company to report EPS of $3.44 for fiscal 2013.  Full Article

Search Stocks